Marshall Wace North America’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Marshall Wace North America’s Portfolio SCLN Stock Details SCLN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$9.28M	Buy
2017 Q2	$2.67M	Buy
2017 Q1	$195K	Buy